MTOR and nonpapillary renal cell carcinoma: The metabolic reprogramming features of ccRCC include altered metabolic pathways associated with VHL gene inactivation and Ras-PI3K-AKT-mTOR pathway activation, involving aerobic glycolysis, fatty acid metabolism, and tryptophan, glutamine, and arginine utilization.